NCT05217732View on ClinicalTrials.gov

Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

August 29, 2022

Study Completion Date

December 19, 2022

Conditions
Safety IssuesTolerancePharmacokineticsFood Effect
Interventions
DRUG

ZX-7101A

tablet

DRUG

Placebo

Tablet

Trial Locations (1)

Unknown

Fudan University affiliated Huashan Hospital, Shanghai

Sponsors
All Listed Sponsors
lead

Nanjing Zenshine Pharmaceuticals

INDUSTRY

NCT05217732 - Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volunteers | Biotech Hunter | Biotech Hunter